Want to see HK:9885 full AI Analyst Report?
9885 Stock Chart & Stats
HK$5.16
HK$0.08(1.41%)
At close: 4:00 PM EST
HK$5.16
HK$0.08(1.41%)
Day’s Range― - ―
52-Week RangeHK$2.96 - HK$12.66
Previous CloseN/A
Volume1.48M
Average Volume (3M)9.20M
Market Cap
HK$2.29B
Enterprise ValueHK$3.00K
Total Cash (Recent Filing)HK$3.38B
Total Debt (Recent Filing)HK$2.77B
Price to Earnings (P/E)12.8
Beta0.61
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.71%
Share Statistics
EPS (TTM)0.22
Shares Outstanding691,799,440
10 Day Avg. Volume7,414,414
30 Day Avg. Volume9,200,413
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)1.37
Price to Sales (P/S)0.16
P/FCF Ratio5.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.38
Revenue Forecast (FY)HK$23.42B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationConsistently positive operating and free cash flow through 2022–2025, with FCF rising ~27% in 2025, indicates durable internal funding. This supports reinvestment, dividends or debt reduction without relying on external capital, strengthening long-term financial resilience.
Revenue Growth And Return To ProfitabilitySteady revenue growth into 2025 and an inflection to positive EBIT and net income show the business scaling and operational improvements taking hold. This structural recovery suggests the core model is stabilizing and can sustain earnings improvement beyond short-term cycles.
Improved Equity PositionRestoring positive equity and building to ~2.44B by 2025 materially reduces insolvency risk versus prior years with negative equity. A stronger equity base enhances borrowing capacity, provides a buffer against losses and supports longer-term strategic flexibility.
Bears Say
Very Thin MarginsGross margin near 11% and net margin below 1% are unusually low for a software application business, leaving minimal operating leverage. This makes profits highly sensitive to modest cost increases or pricing pressure and constrains capital for R&D or sales scale-ups.
Rising LeverageDebt rising to ~2.77B and debt-to-equity around 1.13 markedly increases financial risk versus prior low-leverage years. Higher leverage reduces flexibility for investment, raises interest exposure and amplifies downside in a low-margin environment, limiting strategic options.
Low Cash Conversion Relative To SalesDespite positive absolute cash flow, operating cash remains small relative to revenue, indicating weak cash conversion. This limits internally available growth capital and makes free cash flow vulnerable to working-capital swings or revenue declines, challenging scalability.
YSB Inc. News
9885 FAQ
What was YSB Inc.’s price range in the past 12 months?
YSB Inc. lowest stock price was HK$2.96 and its highest was HK$12.66 in the past 12 months.
What is YSB Inc.’s market cap?
YSB Inc.’s market cap is HK$2.29B.
When is YSB Inc.’s upcoming earnings report date?
YSB Inc.’s upcoming earnings report date is Aug 20, 2026 which is in 4 days.
How were YSB Inc.’s earnings last quarter?
YSB Inc. released its earnings results on Mar 23, 2026. The company reported HK$0.122 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is YSB Inc. overvalued?
According to Wall Street analysts YSB Inc.’s price is currently Overvalued.
Does YSB Inc. pay dividends?
YSB Inc. pays a Notavailable dividend of HK$0.125 which represents an annual dividend yield of 3.71%. See more information on YSB Inc. dividends here
What is YSB Inc.’s EPS estimate?
YSB Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does YSB Inc. have?
YSB Inc. has 691,799,440 shares outstanding.
What happened to YSB Inc.’s price movement after its last earnings report?
YSB Inc. reported an EPS of HK$0.122 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.088%.
Which hedge fund is a major shareholder of YSB Inc.?
Currently, no hedge funds are holding shares in HK:9885
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
YSB Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.66%
12-Months-Change
Fundamentals
Return on Equity
3.71%
Trailing 12-Months
Asset Growth
21.86%
Trailing 12-Months
Company Description
YSB Inc.
YSB Inc. provides a comprehensive digital platform tailored for the Chinese pharmaceutical sector, supporting a wide array of stakeholders such as drug companies, distributors, vendors, pharmacies, and primary healthcare facilities. Its key offerings feature ClouDiagnos, a specialized diagnostic testing service; wePharmacy, an intelligent, unmanned pharmaceutical booth accessible 24/7 that facilitates connections between customers and professional pharmacist services; a suite of Software-as-a-Service (SaaS) solutions; and YSB eLearn, which delivers online courses to prepare individuals for pharmacist qualification examinations. Beyond its digital offerings, the company engages in the wholesale and retail distribution of pharmaceutical and healthcare merchandise, and additionally provides medical testing services. The company was established in 2015 and is headquartered in Guangzhou, China.
Technical Analysis
China Youzan
―
Kingdee International Software Group Co
―
Weimob
―
Chanjet Information Technology Co., Ltd. Class H
―
Baiwang Co., Ltd. Class H
―